• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有早发性冠心病的法裔加拿大人的心血管危险因素和脂蛋白谱:国家胆固醇教育计划II的影响

Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.

作者信息

McNicoll S, Latour Y, Rondeau C, Bouthillier D, Davignon J, Genest J

机构信息

Cardiovascular Genetics Laboratory, Institut de Recherches Cliniques de Montréal, Québec.

出版信息

Can J Cardiol. 1995 Feb;11(2):109-16.

PMID:7866933
Abstract

BACKGROUND

Coronary artery disease (CAD) is the major cause of death in Canadian adults. Regional differences in the prevalence of CAD in Canada are due, in part, to differences in cardiovascular risk factor distribution. Two hundred and forty-nine patients of predominantly French Canadian descent (greater than 90%), aged less than 60 years (202 men and 47 women) with angiographically documented CAD were examined in a cardiology secondary prevention clinic and their cardiovascular risk factors and lipoprotein cholesterol levels were determined.

OBJECTIVES

To determine the prevalence of cardiovascular risk factors in a group of French Canadian subjects compared with subjects screened for the Quebec Heart Health Survey and to determine the impact of the National Cholesterol Education Program II (NCEP II) on screening and treatment of these patients.

METHODS

Observation study of free-living subjects with CAD, compared with a reference group.

RESULTS

Mean ages were 48.6 +/- 6.8 and 50.6 +/- 6.4 years for men and women, respectively. On average, the patients were on a diet containing approximately 31% of calories as fat, with 9.7% as saturated fats at the time of blood sampling. The mean number of risk factors was the same in men and women (3.5 +/- 1.2 for men versus 3.2 +/- 1.3 for women; P not significant) but their prevalence differed between sexes. Family history of CAD was seen in 78.5% of men versus 77.3% of women (P not significant), smoking (defined as more than 10 cigarettes per day in the year preceding the clinical evaluation) in 45.7% of men versus 41.9% of women (P not significant), a history of smoking in 75.5% of men versus 69.8% of women (P not significant) and diabetes in 14.7% of men and 25% of women (P not significant). There was less hypertension in men (31.4% versus 52.3%, P = 0.015) and fewer men had a low density lipoprotein cholesterol of 3.4 mmol/L or greater (66.8% in men versus 83% in women, P < 0.05). Men, however, had a higher prevalence of reduced high density lipoprotein cholesterol (less than 0.9 mmol/L, 57.4% in men versus 31.9% in women, P < 0.01). Only approximately 5% of premature CAD patients had familial hypercholesterolemia. Compared with a reference group from the Quebec Heart Health Survey, men and women with CAD had a higher prevalence of cardiovascular risk factors. With a cut-off point for total cholesterol of 5.2 mmol/L, 26.2% of men and 17% of women had 'normal' cholesterol levels; of these, 67.9% of men and 25% of women had high density lipoprotein less than 0.9 mmol/L.

CONCLUSIONS

French Canadian men and women with CAD have a high prevalence of all cardiovascular risk factors. The patients are representative of the Montreal urban area and findings of the present study may not apply to the Quebec population with respect to the prevalence of risk factors. Under the treatment recommendations of NCEP II, 66.8% of men and 83% of women are candidates for drug therapy of dyslipoproteinemia aimed at reducing low density lipoprotein cholesterol levels. According to these data, cardiovascular risk stratification must be based on a complete lipoprotein profile or misclassification, especially in men, may occur.

摘要

背景

冠状动脉疾病(CAD)是加拿大成年人的主要死因。加拿大CAD患病率的地区差异部分归因于心血管危险因素分布的不同。在一家心脏病二级预防诊所对249名主要为法裔加拿大人后裔(超过90%)、年龄小于60岁(202名男性和47名女性)且经血管造影证实患有CAD的患者进行了检查,并测定了他们的心血管危险因素和脂蛋白胆固醇水平。

目的

确定一组法裔加拿大受试者中心血管危险因素的患病率,并与魁北克心脏健康调查筛查的受试者进行比较,同时确定国家胆固醇教育计划II(NCEP II)对这些患者筛查和治疗的影响。

方法

对患有CAD的自由生活受试者进行观察性研究,并与一个参考组进行比较。

结果

男性和女性的平均年龄分别为48.6±6.8岁和50.6±6.4岁。平均而言,患者在采血时的饮食中脂肪提供的热量约为31%,其中饱和脂肪占9.7%。男性和女性的危险因素平均数量相同(男性为3.5±1.2,女性为3.2±1.3;P无显著性差异),但其患病率在性别之间存在差异。CAD家族史在78.5%的男性和77.3%的女性中出现(P无显著性差异),吸烟(定义为临床评估前一年每天吸烟超过10支)在45.7%的男性和41.9%的女性中出现(P无显著性差异),有吸烟史在75.5%的男性和69.8%的女性中出现(P无显著性差异),糖尿病在14.7%的男性和25%的女性中出现(P无显著性差异)。男性高血压患者较少(31.4%对52.3%,P = 0.015),低密度脂蛋白胆固醇≥3.4 mmol/L的男性也较少(男性为66.8%,女性为83%,P < 0.05)。然而,男性高密度脂蛋白胆固醇降低(<0.9 mmol/L)的患病率更高(男性为57.4%,女性为31.9%,P < 0.01)。只有约5%的早发性CAD患者患有家族性高胆固醇血症。与魁北克心脏健康调查的参考组相比,患有CAD的男性和女性心血管危险因素的患病率更高。总胆固醇切点为5.2 mmol/L时,26.2%的男性和17%的女性胆固醇水平“正常”;其中,67.9%的男性和25%的女性高密度脂蛋白<0.9 mmol/L。

结论

患有CAD的法裔加拿大男性和女性所有心血管危险因素的患病率都很高。这些患者代表了蒙特利尔市区,本研究结果在危险因素患病率方面可能不适用于魁北克人群。根据NCEP II的治疗建议,66.8%的男性和83%的女性是旨在降低低密度脂蛋白胆固醇水平的血脂异常药物治疗的候选者。根据这些数据,心血管风险分层必须基于完整的脂蛋白谱,否则可能会出现错误分类,尤其是在男性中。

相似文献

1
Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.患有早发性冠心病的法裔加拿大人的心血管危险因素和脂蛋白谱:国家胆固醇教育计划II的影响
Can J Cardiol. 1995 Feb;11(2):109-16.
2
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.法裔加拿大人早发性冠状动脉疾病中的代谢因素聚集、脂蛋白胆固醇、载脂蛋白B、脂蛋白(a)和载脂蛋白E表型
Can J Cardiol. 1997 Mar;13(3):253-60.
3
Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.加拿大人群中高血浆甘油三酯合并低高密度脂蛋白胆固醇水平的患病率及其与吸烟、高血压、肥胖、糖尿病、久坐不动和低密度脂蛋白胆固醇水平的关联。加拿大心脏健康调查研究小组。
Can J Cardiol. 1999 Apr;15(4):428-33.
4
The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.女性高脂血症的患病率及其与口服避孕药、性激素替代疗法和非脂质冠状动脉疾病危险因素的关联。加拿大心脏健康调查研究小组。
Can J Cardiol. 1999 Apr;15(4):419-27.
5
Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease.法裔加拿大早发冠状动脉疾病患者的血管紧张素转换酶插入/缺失多态性
Pathol Biol (Paris). 1998 May;46(5):295-300.
6
Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.加拿大成年人肥胖症及其与心血管疾病风险因素的关系。加拿大心脏健康调查研究小组。
CMAJ. 1992 Jun 1;146(11):2009-19.
7
Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.加拿大两个省份(魁北克省和萨斯喀彻温省)人群血浆载脂蛋白A-I和B的参考值及其与非脂质风险因素的关联。加拿大心脏健康调查研究小组。
Can J Cardiol. 1999 Apr;15(4):409-18.
8
A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.一项基于三级护理医院的针对已确诊冠状动脉疾病的常规风险因素(包括血脂谱)的研究。
Indian Heart J. 2003 May-Jun;55(3):234-40.
9
Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.高密度脂蛋白胆固醇升高患者的冠状动脉疾病危险因素。
Am J Cardiol. 2007 Jan 1;99(1):1-4. doi: 10.1016/j.amjcard.2006.07.053. Epub 2006 Nov 2.
10
High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.旁遮普邦巴蒂亚社区多种冠状动脉危险因素的高患病率:斋浦尔心脏观察-3。
Indian Heart J. 2004 Nov-Dec;56(6):646-52.

引用本文的文献

1
Hypertensive Disorders of Pregnancy.妊娠高血压疾病。
Methodist Debakey Cardiovasc J. 2024 Mar 14;20(2):4-12. doi: 10.14797/mdcvj.1305. eCollection 2024.
2
Prevalence and patterns of multimorbidity among linguistic groups of patients receiving home care in Ontario: a retrospective cohort study.安大略省接受家庭护理的患者语言群体的共病患病率和模式:一项回顾性队列研究。
BMC Geriatr. 2023 Nov 9;23(1):725. doi: 10.1186/s12877-023-04267-5.